Evidence map›Paper›PMID 31906839›Full record

ArticleCurrent HIV research2020

Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.

Patrick E H Jackson, Godfrey Dzhivhuho, David Rekosh, Marie-Louise Hammarskjold

Open access · greenAbstract read
In one paragraph

Article in Current HIV research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Role of RNA Modification in HIV-1 Infection.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Patrick E H JacksonDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia United States.
Godfrey DzhivhuhoMyles H. Thaler Center for HIV and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia, United States.
David RekoshMyles H. Thaler Center for HIV and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia, United States.
Marie-Louise HammarskjoldMyles H. Thaler Center for HIV and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia, United States.
University of Virginia · US

Funding

HIV, HERV-K and Human CancerR01CA206275 · NCI · UNIVERSITY OF VIRGINIA · PI HAMMARSKJOLD, MARIE-LOUISE, REKOSH, DAVID M · 2017 to 2021
$2.2M
Clinical Implications of HIV-1 Rev-Rev Response Element Functional Activity VariationK08AI136671 · NIAID · UNIVERSITY OF VIRGINIA · PI JACKSON, PATRICK EVAN HAGER · 2018 to 2022
$959k
Role of HIV Rev in Reactivation from LatencyR21AI134208 · NIAID · UNIVERSITY OF VIRGINIA · PI HAMMARSKJOLD, MARIE-LOUISE, REKOSH, DAVID M · 2017 to 2018
$443k
NCI NIH HHS R01 CA206275NIAID NIH HHS K08 AI136671NIAID NIH HHS R21 AI134208
6 · The paper itself

Abstract

backgroundTo complete its replication cycle, HIV-1 requires the nucleocytoplasmic export of intron-containing viral mRNAs. This process is ordinarily restricted by the cell, but HIV overcomes the block by means of a viral protein, Rev, and an RNA secondary structure found in all unspliced and incompletely spliced viral mRNAs called the Rev Response Element (RRE). In vivo activity of the Rev-RRE axis requires Rev binding to the RRE, oligomerization of Rev to form a competent ribonucleoprotein complex, and recruitment of cellular factors including Crm1 and RanGTP in order to export the targeted transcript. Sequence variability is observed among primary isolates in both Rev and the RRE, and the activity of both can be modulated through relatively small sequence changes. Primary isolates show differences in Rev-RRE activity and a few studies have found a correlation between lower Rev-RRE activity and slower progression of clinical disease. Lower Rev-RRE activity has also been associated with the evasion of cytotoxic T lymphocyte mediated killing.

conclusionThe HIV-1 Rev-RRE regulatory axis is an understudied mechanism by which viral adaptation to diverse immune milieus may take place. There is evidence that this adaptation plays a role in HIV pathogenesis, particularly in immune evasion and latency, but further studies with larger sample sizes are warranted.

Indexed as

Alternative SplicingGenes, envGenetic VariationHIV-1HIV InfectionsHumansrev Gene Products, Human Immunodeficiency VirusRibonucleoproteinsRNA, ViralVirus Replicationrev Gene Products, Human Immunodeficiency VirusRibonucleoproteinsRNA, ViralHIV latencyHIV RevHIV Rev Response ElementHIV sequence variationpost-transcriptional gene regulation.RNA splicing

Identifiers

PMID31906839
PMCPMC7113094
OpenAlexW3000191656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.